This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: National Cheng-Kung University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Jie-Ning Li in Drug Resistance Evaluation
Introduction
Jie-Ning Li is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of drug resistance evaluation, particularly in hormone therapy. His innovative approach aims to improve treatment outcomes for patients undergoing such therapies.
Latest Patents
Jie-Ning Li holds a patent for a method of evaluating drug resistance and treatment effect. The patent outlines a systematic approach that includes measuring the primary level of TRBP in a subject, administering an effective amount of tamoxifen or its analogs, and subsequently measuring the TRBP level again. This method allows for the determination of tamoxifen resistance based on the level change of TRBP in the subject.
Career Highlights
Li is affiliated with National Cheng-Kung University, where he continues to advance research in his field. His work has garnered attention for its potential to enhance the effectiveness of hormone therapies in clinical settings.
Collaborations
Some of his notable coworkers include Pai-Sheng Chen and Yao-Lung Kuo, who contribute to the collaborative research efforts at the university.
Conclusion
Jie-Ning Li's innovative methods in evaluating drug resistance represent a significant advancement in hormone therapy. His contributions are poised to improve patient care and treatment efficacy in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile